53
Growth Score in past quarter
pts
Heat Score 53 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1242570
NegotiumBio provides an outsourced contract manufacturing strategy, coupled negotiating, and risk assessment services.
- Christoph Becker: CEO & PartnerPast Role: Novartis, Global Head of Procurement Technical Research & Development and Cell & Gene Therapy
About the Company
NegotiumBio's mission is to assist pharmaceutical and biotechnology firms in developing and implementing outsourcing strategies for any drug modality. They support clients in identifying strategic short- and long-term manufacturing partners who can match their strict speed, accuracy, and efficiency requirements. This concentrates company
scientists' efforts on developing breakthrough cures and enhancing patient care. Furthermore, they help in the development of raw material GMP and non-GMP management systems through direct OEM and consolidation techniques utilizing digital cataloging and marketplace cloud capabilities.